The urinary excretion of glutarylcarnitine is an informative tool in the biochemical diagnosis of glutaric acidemia type I

S. Tortorelli, S. H. Hahn, T. M. Cowan, T. G. Brewster, P. Rinaldo, D. Matern

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Glutaric acidemia type I (GA-1) is a progressive neurodegenerative inborn error of metabolism that typically manifests acutely in infants during an intercurrent illness. The diagnosis is established biochemically by the detection of glutaric acid and 3-hydroxy glutaric acid in urine and glutarylcarnitine in plasma. However, some patients excrete only small amounts of glutaric acid and may be overlooked, especially if the plasma concentration of glutarylcarnitine is not elevated. To test the hypothesis that measuring the excretion of glutarylcarnitine may improve the recognition of GA-1 patients without significant glutaric aciduria, urine glutarylcarnitine was analyzed in 14 cases. Five of them lacked significant glutaric aciduria, 9 (of 10 available) had a normal plasma glutarylcarnitine concentration. As controls, we also evaluated 54 subjects with glutaric aciduria secondary to other causes (16-7509 mmol/mol creatinine; reference range: <15; no significant amounts of 3-hydroxy glutaric acid detectable). The excretion of glutarylcarnitine was significantly elevated in all GA-1 patients (14-522 mmol/mol creatinine; reference range: <5.2) and in none of the controls with glutaric aciduria. These findings suggest that the urinary excretion of glutarylcarnitine is a specific biochemical marker of GA-1 which could be particularly useful in the work up of patients with suggestive clinical manifestations but without glutaric aciduria and with normal plasma acylcarnitine profiles.

Original languageEnglish (US)
Pages (from-to)137-143
Number of pages7
JournalMolecular Genetics and Metabolism
Volume84
Issue number2
DOIs
StatePublished - Feb 2005

Fingerprint

Plasmas
Hydroxy Acids
Creatinine
Reference Values
Urine
Inborn Errors Metabolism
glutarylcarnitine
Glutaric Acidemia I
Metabolism
Biomarkers
G(A1) ganglioside
glutaric acid
acylcarnitine

Keywords

  • Acylcarnitine analysis
  • Biochemical genetics
  • Glutaric acidemia type I
  • Organic acid analysis
  • Organic aciduria

ASJC Scopus subject areas

  • Biochemistry
  • Genetics
  • Endocrinology, Diabetes and Metabolism

Cite this

The urinary excretion of glutarylcarnitine is an informative tool in the biochemical diagnosis of glutaric acidemia type I. / Tortorelli, S.; Hahn, S. H.; Cowan, T. M.; Brewster, T. G.; Rinaldo, P.; Matern, D.

In: Molecular Genetics and Metabolism, Vol. 84, No. 2, 02.2005, p. 137-143.

Research output: Contribution to journalArticle

Tortorelli, S. ; Hahn, S. H. ; Cowan, T. M. ; Brewster, T. G. ; Rinaldo, P. ; Matern, D. / The urinary excretion of glutarylcarnitine is an informative tool in the biochemical diagnosis of glutaric acidemia type I. In: Molecular Genetics and Metabolism. 2005 ; Vol. 84, No. 2. pp. 137-143.
@article{160a30b6a52c450c8ced92171568ae70,
title = "The urinary excretion of glutarylcarnitine is an informative tool in the biochemical diagnosis of glutaric acidemia type I",
abstract = "Glutaric acidemia type I (GA-1) is a progressive neurodegenerative inborn error of metabolism that typically manifests acutely in infants during an intercurrent illness. The diagnosis is established biochemically by the detection of glutaric acid and 3-hydroxy glutaric acid in urine and glutarylcarnitine in plasma. However, some patients excrete only small amounts of glutaric acid and may be overlooked, especially if the plasma concentration of glutarylcarnitine is not elevated. To test the hypothesis that measuring the excretion of glutarylcarnitine may improve the recognition of GA-1 patients without significant glutaric aciduria, urine glutarylcarnitine was analyzed in 14 cases. Five of them lacked significant glutaric aciduria, 9 (of 10 available) had a normal plasma glutarylcarnitine concentration. As controls, we also evaluated 54 subjects with glutaric aciduria secondary to other causes (16-7509 mmol/mol creatinine; reference range: <15; no significant amounts of 3-hydroxy glutaric acid detectable). The excretion of glutarylcarnitine was significantly elevated in all GA-1 patients (14-522 mmol/mol creatinine; reference range: <5.2) and in none of the controls with glutaric aciduria. These findings suggest that the urinary excretion of glutarylcarnitine is a specific biochemical marker of GA-1 which could be particularly useful in the work up of patients with suggestive clinical manifestations but without glutaric aciduria and with normal plasma acylcarnitine profiles.",
keywords = "Acylcarnitine analysis, Biochemical genetics, Glutaric acidemia type I, Organic acid analysis, Organic aciduria",
author = "S. Tortorelli and Hahn, {S. H.} and Cowan, {T. M.} and Brewster, {T. G.} and P. Rinaldo and D. Matern",
year = "2005",
month = "2",
doi = "10.1016/j.ymgme.2004.09.016",
language = "English (US)",
volume = "84",
pages = "137--143",
journal = "Molecular Genetics and Metabolism",
issn = "1096-7192",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - The urinary excretion of glutarylcarnitine is an informative tool in the biochemical diagnosis of glutaric acidemia type I

AU - Tortorelli, S.

AU - Hahn, S. H.

AU - Cowan, T. M.

AU - Brewster, T. G.

AU - Rinaldo, P.

AU - Matern, D.

PY - 2005/2

Y1 - 2005/2

N2 - Glutaric acidemia type I (GA-1) is a progressive neurodegenerative inborn error of metabolism that typically manifests acutely in infants during an intercurrent illness. The diagnosis is established biochemically by the detection of glutaric acid and 3-hydroxy glutaric acid in urine and glutarylcarnitine in plasma. However, some patients excrete only small amounts of glutaric acid and may be overlooked, especially if the plasma concentration of glutarylcarnitine is not elevated. To test the hypothesis that measuring the excretion of glutarylcarnitine may improve the recognition of GA-1 patients without significant glutaric aciduria, urine glutarylcarnitine was analyzed in 14 cases. Five of them lacked significant glutaric aciduria, 9 (of 10 available) had a normal plasma glutarylcarnitine concentration. As controls, we also evaluated 54 subjects with glutaric aciduria secondary to other causes (16-7509 mmol/mol creatinine; reference range: <15; no significant amounts of 3-hydroxy glutaric acid detectable). The excretion of glutarylcarnitine was significantly elevated in all GA-1 patients (14-522 mmol/mol creatinine; reference range: <5.2) and in none of the controls with glutaric aciduria. These findings suggest that the urinary excretion of glutarylcarnitine is a specific biochemical marker of GA-1 which could be particularly useful in the work up of patients with suggestive clinical manifestations but without glutaric aciduria and with normal plasma acylcarnitine profiles.

AB - Glutaric acidemia type I (GA-1) is a progressive neurodegenerative inborn error of metabolism that typically manifests acutely in infants during an intercurrent illness. The diagnosis is established biochemically by the detection of glutaric acid and 3-hydroxy glutaric acid in urine and glutarylcarnitine in plasma. However, some patients excrete only small amounts of glutaric acid and may be overlooked, especially if the plasma concentration of glutarylcarnitine is not elevated. To test the hypothesis that measuring the excretion of glutarylcarnitine may improve the recognition of GA-1 patients without significant glutaric aciduria, urine glutarylcarnitine was analyzed in 14 cases. Five of them lacked significant glutaric aciduria, 9 (of 10 available) had a normal plasma glutarylcarnitine concentration. As controls, we also evaluated 54 subjects with glutaric aciduria secondary to other causes (16-7509 mmol/mol creatinine; reference range: <15; no significant amounts of 3-hydroxy glutaric acid detectable). The excretion of glutarylcarnitine was significantly elevated in all GA-1 patients (14-522 mmol/mol creatinine; reference range: <5.2) and in none of the controls with glutaric aciduria. These findings suggest that the urinary excretion of glutarylcarnitine is a specific biochemical marker of GA-1 which could be particularly useful in the work up of patients with suggestive clinical manifestations but without glutaric aciduria and with normal plasma acylcarnitine profiles.

KW - Acylcarnitine analysis

KW - Biochemical genetics

KW - Glutaric acidemia type I

KW - Organic acid analysis

KW - Organic aciduria

UR - http://www.scopus.com/inward/record.url?scp=12844261741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12844261741&partnerID=8YFLogxK

U2 - 10.1016/j.ymgme.2004.09.016

DO - 10.1016/j.ymgme.2004.09.016

M3 - Article

C2 - 15670719

AN - SCOPUS:12844261741

VL - 84

SP - 137

EP - 143

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

SN - 1096-7192

IS - 2

ER -